53 related articles for article (PubMed ID: 678491)
1. Production of fibrinolytic enzymes by macrophages on intrauterine contraceptive devices.
Foley ME; Jenkins DM; McNicol GP
Br J Obstet Gynaecol; 1978 Jul; 85(7):551-6. PubMed ID: 678491
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
3. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
[TBL] [Abstract][Full Text] [Related]
4. Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial.
Arowojolu AO; Otolorin EO; Ladipo OA
Afr J Med Med Sci; 1995 Mar; 24(1):59-65. PubMed ID: 7495202
[TBL] [Abstract][Full Text] [Related]
5. Real-time ultrasound in locating intrauterine contraceptive devices.
Nelson LH; Miller JB
Obstet Gynecol; 1979 Dec; 54(6):711-4. PubMed ID: 514557
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
[TBL] [Abstract][Full Text] [Related]
7. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
Pan J; Yu Y; Chen G
Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
[TBL] [Abstract][Full Text] [Related]
8. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
Roy S; Shaw ST
Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
[TBL] [Abstract][Full Text] [Related]
9. Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices.
Oyelola OO; Okonofua FE; Adediran TO
East Afr Med J; 1994 Apr; 71(4):268-70. PubMed ID: 8062778
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator activity in lung and alveolar macrophages of rats exposed to graded single doses of gamma rays to the right hemithorax.
Ts'ao C; Ward WF
Radiat Res; 1985 Sep; 103(3):393-402. PubMed ID: 4041064
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the effectiveness of the Lippes Loop, the Copper-T-200, and the Nova-T intrauterine contraceptive devices in Lagos, Nigeria.
Oyediran MA; Akinla OA; Aderinola EA
Int J Fertil; 1982; 27(2):109-12. PubMed ID: 6126444
[TBL] [Abstract][Full Text] [Related]
12. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
13. [Clinical evaluation of the progesterone T intrauterine device].
Pizarro Orchard E; Gómez Rogers C
Rev Chil Obstet Ginecol; 1980; 45(2):87-98. PubMed ID: 6765370
[TBL] [Abstract][Full Text] [Related]
14. A comparison of the delta copper T and the copper T 200 in Bologna, Italy.
Melega C; Biscontin S; Canedi L; Marchesini FP; Tirelli S; Bartolotti T; Flamigni C
Acta Eur Fertil; 1986; 17(1):39-41. PubMed ID: 3727892
[TBL] [Abstract][Full Text] [Related]
15. Fibrinolysis in idiopathic menorrhagia.
Bisht D; Gupta SC; Kaushik S; Ganguli G; Mital VP
Indian J Pathol Microbiol; 1991 Jul; 34(3):200-2. PubMed ID: 1818856
[TBL] [Abstract][Full Text] [Related]
16. Uterine bleeding in rhesus monkeys after insertion of polyethylene and copper containing polyethylene intrauterine contraceptive devices.
Chandra H; Kar AB; Dasgupta PR
Indian J Exp Biol; 1973 May; 11(3):228. PubMed ID: 4205756
[TBL] [Abstract][Full Text] [Related]
17. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
18. Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells.
Aikens ML; Grenett HE; Benza RL; Tabengwa EM; Davis GC; Booyse FM
Alcohol Clin Exp Res; 1998 Apr; 22(2):375-81. PubMed ID: 9581643
[TBL] [Abstract][Full Text] [Related]
19. Efficiency and acceptability of intrauterine contraceptive devices.
Trutko NS
Acta Med Hung; 1986; 43(2):103-8. PubMed ID: 3588154
[TBL] [Abstract][Full Text] [Related]
20. The production of plasminogen activator by afferent but not efferent lymph cells emigrating from chronic granulomatous lesions in sheep.
Wasi S; Vadas P; Chin GW; Movat HZ; Hay JB
J Immunol; 1982 Mar; 128(3):1076-82. PubMed ID: 7199065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]